A Biomarker for Selecting Extended Adjuvant Endocrine Therapy in Breast Cancer
Mark Pegram, MD
The HOXB13/IL17BR ratio is standardizing which early-stage, HR+ breast cancer patients are selected for extended adjuvant endocrine therapy
Breast Cancer
NIH Releases Annual Report to the Nation
National Institutes of Health
Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
Earlier Mammograms for Women with Family History of Cancer May Not Be Needed
University of California - Davis Health System
Improving guidelines for when to initiate screening could reduce the potential harms
Next-Generation Liquid Biopsy Detects Nano-Sized Signs of Breast Cancer
University of Southern California
Researchers find remarkable results with the blood test in a small group of breast cancer patients
New Genetic Study Reveals Why Some Women Get Aggressive Breast, Ovarian Cancer
University of Bergen
Findings could have significant implications for understanding and diagnosing these cancers
The Tumor Environment Can Affect Breast Cancer Prognosis
Lund University
The interplay between the patient’s BMI, tumor size, and cancer-specific proteins is of importance for the prognosis
Accurate Diagnostic Mammography Outcomes Vary by Racial and Ethnic Groups
UNC Lineberger Comprehensive Cancer Center
Radiology facilities and imaging process cited as factors that may lead to some disparities
Potential New Marker to Personalized Therapy for Breast Cancer
University of Southampton
Study discovers that "crown-like structures" surrounding breast tumors could hinder their response to therapy
Does Multiple Sclerosis Play a Role in Cancer Screening and Diagnosis?
American Academy of Neurology
New study examines breast cancer and colorectal cancer detection in people with MS
How Often Does Breast Cancer Overdiagnosis Occur?
Rachel Muenz
While overdiagnosis remains an issue, new research suggests it occurs far less often than previously believed